APC and cancer: While the results of validation of the above inhibitors based on cultured-cell and xenograft models shed light on novel anti-cancer strategy, preclinical study with combination to various chemo drugs in different patient-derived xenograft models will further validate and enhance the potential of APC inhibitors in future’s anti-cancer treatment.